Riskpilot← Back to searchSign inGet full accessKaramed AB
ABActiveOrg 5569395261Stenhuggarvägen 59Medical specialists activities · NACE 8622Est. 20130 employees
Revenue 2024
SEK 240K
-49% vs 2023
EBITDA margin
65.0%
-61% vs 2023
Equity ratio
72.2%
Financial strength
Net profit 2024
SEK 215K
-17% vs 2023
| Revenue | SEK 240K | -49% |
| EBITDA | SEK 156K | -61% |
| Net profit | SEK 215K | -17% |
| Total assets | SEK 1,2M | +1% |
| Equity | SEK 837K | +35% |
| Employees | 0 | — |
Legal name
Karamed AB
Org number
5569395261
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
19 augusti 2013
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall erbjuda konsulttjänster inom hälsa, vård och omsorg, utföra vårdtjänster inom både allmän och specialiserad medicin samt därmed förenlig verksamhet.
Address
Stenhuggarvägen 59
Phone
+46739290065
Email
shahriar.ghandi@yahoo.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 626 | 601 | 467 | 240 |
| Staff expenses | — | — | −1 | −6 | −3 |
| EBITDA | −1 | 529 | 544 | 401 | 156 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −1 | 529 | 544 | 401 | 156 |
| Net financials | — | — | 1 | 15 | 13 |
| Profit before tax | −1 | 428 | 409 | 322 | 269 |
| Tax | −0 | −88 | −84 | −64 | −54 |
| Net profit | −1 | 340 | 325 | 258 | 215 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 51 | 633 | 1 171 | 1 146 | 1 160 |
| Equity | 49 | 389 | 714 | 622 | 837 |
| Long-term debt | 0 | 0 | 13 | 34 | 87 |
| Short-term debt | 2 | 143 | 209 | 159 | 5 |
| Total debt | 2 | 143 | 221 | 194 | 92 |
EBITDA margin
65.0%
This company
15.8%
Market median
+311% vs market
20202024
Equity ratio
72.2%
This company
38.2%
Market median
+89% vs market
20202024
Return on equity
25.7%
This company
18.4%
Market median
+40% vs market
20202024
Net profit margin
89.6%
This company
8.1%
Market median
+1006% vs market
20202024
Asset turnover
0.21×
This company
1.12×
Market median
-81% vs market
20202024
Debt / equity
0.39×
This company
0.62×
Market median
+37% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SG Chief Executive Officer | Chief Executive Officer | 2020 |
| Former (1) | ||
FA Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Karamed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Fereshteh Abdollahi | Chief Executive Officer | 0 companies |
| Shahriar Ghandi | Chief Executive Officer | 0 companies |
| Maziar Ghandi | Deputy Board Member | 0 companies |